Tevogen Bio is driven by a team of highly experienced industry leaders and distinguished scientists with drug development and global product launch experience. Tevogen Bio’s leadership believes that ...

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

Craig-Hallum analyst Matt Hewitt maintained a Buy rating on Codexis (CDXS – Research Report) today. The company’s shares closed yesterday at ...